Elevai Labs, Inc. Common Stock
ELAB
$3.04+1.50%
End of day · as of Oct 16, 2026, 5:30 AM ET
Mkt cap
$6.50M
EV/Sales
1.86
P/E ratio
N/A
FY2025 Revenue
$590,084
EPS (FY2025)
N/A
Gross Margin (FY2025)
31.40%
Profit Margin (FY2025)
-1313.00%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Latest reported ELAB revenue for 2025-12-31 was $590.1K. Net income was -$7.7M. ELAB currently screens at market cap $6.5M.
Use this ELAB research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ELAB income, balance, and cash tables.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company in the Healthcare sector.
Latest cached Elevai Labs, Inc. Common Stock (ELAB) revenue for Dec 31, 2025 was $590.1K. Net income was -$7.7M. Statements: https://lician.com/financials/elab
Elevai Labs, Inc. Common Stock (ELAB) market capitalization is $6.5M on the latest cached snapshot.
Elevai Labs, Inc. Common Stock (ELAB) cached previous close $3.00; day range $2.79 – $3.06; volume 15,662. Session quote: https://lician.com/quote/elab
Elevai Labs, Inc. Common Stock (ELAB) latest cached earnings event is "ELAB earnings" on Aug 18, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ELAB filing is 8-K · Sep 18, 2026. Filings: https://lician.com/sec/elab